DUX4 encodes a transcription factor that is believed to be involved in myogenic differentiation, and its anomalous expression in adult muscle in FSHD provides an attractive target for knockdown or inhibitory therapies. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.